Voyager Therapeutics, Inc. VYGR
1.76 USD -0.06 (-3.56%)
At closeNov 12, 2026, 7:38 AM EST
1.77 +0.01 +0.57%
Pre-market · Nov 12, 7:38 AM ET
1.75 Day range 1.84
1.68 52-week range 5.48
- YTD
- -55.22%
- 1 year
- -58.69%
VYGR revenue history
Revenue is income from the company’s ordinary business activities.
40,374,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 40,374,000 | -39,627,000 | -49.53% |
| FY 2024 | 2024-12-31 | 80,001,000 | -170,007,000 | -68.00% |
| FY 2023 | 2023-12-31 | 250,008,000 | 209,101,000 | 511.16% |
| FY 2022 | 2022-12-31 | 40,907,000 | 3,492,000 | 9.33% |
| FY 2021 | 2021-12-31 | 37,415,000 | -133,713,000 | -78.14% |
| FY 2020 | 2020-12-31 | 171,128,000 | 66,737,000 | 63.93% |
| FY 2019 | 2019-12-31 | 104,391,000 | 96,772,000 | 1270.14% |
| FY 2018 | 2018-12-31 | 7,619,000 | -2,516,000 | -24.82% |
| FY 2017 | 2017-12-31 | 10,135,000 | -4,085,000 | -28.73% |
| FY 2016 | 2016-12-31 | 14,220,000 | -3,114,000 | -17.96% |
| FY 2015 | 2015-12-31 | 17,334,000 | 17,334,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.